World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
37370
World Ranking
7094
National Ranking
144

Overview

Johan Askling is affiliated with the Karolinska Institute in Sweden and has contributed extensively to the field of medicine, with a primary focus on rheumatology, genetics, immunology, epidemiology, and hematology. Their research portfolio includes significant work on autoimmune and inflammatory disorders, chronic lymphocytic leukemia, inflammatory bowel disease, psoriasis, and systemic lupus erythematosus.

They have published 476 works in medicine, with 192 publications specifically in rheumatology. Other subfields of study include genetics (60 publications), immunology (42), epidemiology (32), and hematology (28). Their main research topics cover:

  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Inflammatory Bowel Disease
  • Autoimmune and Inflammatory Disorders Research
  • Psoriasis: Treatment and Pathogenesis

Johan Askling's frequent co-authors include Daniela Di Giuseppe, Bénédicte Delcoigne, Merete Lund Hetland, Ulf Lindström, and Thomas Frisell, reflecting ongoing collaborative efforts in their areas of expertise.

Their research has been featured repeatedly in prominent publication venues such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • Journal of Crohn's and Colitis
  • Alimentary Pharmacology & Therapeutics

Significant recent publications include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020, Annals of the Rheumatic Diseases)
  • Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study (2020, The Lancet)
  • Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden (2021, Clinical Epidemiology)
  • Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study (2020, The Lancet. Gastroenterology & Hepatology)
  • FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease (2020, Nature)

Best Publications

  • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

    Eva Baecklund;Anastasia Iliadou;Johan Askling;Anders Ekbom;Anders Ekbom

  • Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up

    Cecilia Söderberg;Per Stål;Per Stål;Johan Askling;Hans Glaumann

  • Cancer Incidence in a Population-Based Cohort of Individuals Hospitalized With Celiac Disease or Dermatitis Herpetiformis

    Johan Askling;Martha Linet;Gloria Gridley;Trond S. Halstensen

  • Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

    J Askling;C M Fored;Eva Baecklund;L Brandt

  • Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

    Johan Askling;C. Michael Fored;Lena Brandt;Eva Baecklund

  • Family History as a Risk Factor for Colorectal Cancer in Inflammatory Bowel Disease

    Johan Askling;Paul W. Dickman;Per Karlen;Olle Broström

  • Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

    J Askling;CM Fored;L Brandt;E Baecklund

  • Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype

    Karin Ekström Smedby;Henrik Hjalgrim;Johan Askling;Ellen T. Chang

  • Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

    Henrik Hjalgrim;Johan Askling;Klaus Rostgaard;Stephen Hamilton-Dutoit

  • Time‐dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

    Johan Askling;C Michael Fored;Lena Brandt;Eva Baecklund

  • Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

    KE Smedby;Måns Åkerman;H Hildebrand;B Glimelius

  • Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta‐analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

    Johan Askling;Kyle Fahrbach;Beth Nordstrom;Susan Ross

  • Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.

    Karin Ekström;Henrik Hjalgrim;Lena Brandt;Eva Baecklund

  • Causes of Death in Patients With Celiac Disease in a Population-Based Swedish Cohort

    Ulrike Peters;Johan Askling;Gloria Gridley;Anders Ekbom

  • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

    Johan Askling;Eva Baecklund;F. Granath;P. Geborek

  • Increased Risk for Cancer Following Sarcoidosis

    Johan Askling;Johan Grunewald;Anders Eklund;Gunnar Hillerdal

  • Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.

    Ola Olén;Ola Olén;Rune Erichsen;Michael C Sachs;Lars Pedersen

  • Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

    Johan Askling;Ronald F. van Vollenhoven;Fredrik Granath;Pauline Raaschou

  • Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

    Maria Elmberg;Rolf Hultcrantz;Anders Ekbom;Lena Brandt

  • Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.

    Sverre Söderlund;Lena Brandt;Annika Lapidus;Per Karlén

Frequent Co-Authors

Anders Ekbom
Anders Ekbom Karolinska Institute
Jonas F. Ludvigsson
Jonas F. Ludvigsson Karolinska Institute
Lars Klareskog
Lars Klareskog Karolinska Institute
Lars Alfredsson
Lars Alfredsson Karolinska Institute
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Christer Sundström
Christer Sundström Uppsala University
Tore Saxne
Tore Saxne Lund University
Scott Montgomery
Scott Montgomery Örebro University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens many diverse professional avenues beyond traditional MD and DO programs. Many students and healthcare professionals are turning to flexible online programs to boost their qualifications or shift their career focus. For nurses looking to specialize in mental health, online psych np programs offer a convenient way to earn a degree and prepare for advanced psychiatric nurse practitioner roles.

Healthcare management is another fast-growing field, and earning an online health management degree can pave the way for leadership positions in hospitals, clinics, and insurance organizations. For those seeking a cost-effective path to senior administrative roles, the cheapest mha programs online provide valuable training in healthcare systems, policy, and operations.

Additionally, nurses aiming for the pinnacle of clinical practice may benefit from pursuing the cheapest dnp programs online, which focus on evidence-based practice and leadership at the doctoral level. Whether your interests lie in management, advanced nursing practice, or administration, online degrees can help you advance your career on your terms.

Best Scientists Citing Johan Askling

Trending Scientists